BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6247634)

  • 21. Susceptibility to varicella virus of certain adults in the southeastern United States.
    Hyams PJ; Vernon S; Eckert D
    Am J Infect Control; 1984 Feb; 12(1):6-9. PubMed ID: 6322621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella susceptibility and vaccine use among young adults enlisting in the United States Navy.
    Ryan MA; Smith TC; Honner WK; Gray GC
    J Med Virol; 2003; 70 Suppl 1():S15-9. PubMed ID: 12627481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella morbidity in Czechoslovakia.
    Trlifajová J; Svandová E; Havrlantová M; Galetková A
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):192-9. PubMed ID: 6251130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroepidemiology of varicella.
    Muench R; Nassim C; Niku S; Sullivan-Bolyai JZ
    J Infect Dis; 1986 Jan; 153(1):153-5. PubMed ID: 3001191
    [No Abstract]   [Full Text] [Related]  

  • 25. Maternal varicella history as a predictor of varicella immune status.
    Silverman NS; Ewing SH; Todi N; Montgomery OC
    J Perinatol; 1996; 16(1):35-8. PubMed ID: 8869538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella.
    De Juanes JR; Gil A; San-Martín M; González A; Esteban J; García de Codes A
    Vaccine; 2005 Feb; 23(12):1434-6. PubMed ID: 15670877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a live varicella vaccine to hospitalized children and its follow-up study.
    Katsushima N; Yazaki N; Sakamoto M; Fujiyama J; Nakagawa M; Okuyama Y; Takahashi M
    Biken J; 1982 Mar; 25(1):29-42. PubMed ID: 6289798
    [No Abstract]   [Full Text] [Related]  

  • 29. Determination of immunity to varicella using an enzyme-linked-immunosorbent-assay.
    Gershon AA; Frey HM; Steinberg SP; Seeman MD; Bidwell D; Voller A
    Arch Virol; 1981; 70(2):169-72. PubMed ID: 6277288
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic evidence of reinfection with varicella-zoster virus.
    Talbot GH; Skros M; Fisher M; Friedman H
    J Infect Dis; 1984 Jun; 149(6):1035-6. PubMed ID: 6330237
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
    Wassilew SW
    MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.
    Steele RW; Coleman MA; Fiser M; Bradsher RW
    Pediatrics; 1982 Oct; 70(4):604-8. PubMed ID: 6289236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A; Wutzler P
    Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
    Chazan B; Colodner R; Teitler N; Chen Y; Raz R
    Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella-Zoster Immunity in US Healthcare Personnel With Self-Reported History of Disease.
    Troiani L; Hill JJ; Consoli S; Weber DJ
    Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1467-8. PubMed ID: 26307155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.